Thursday, July 9, 2026

pharma · Juvenile Neuronal Ceroid Lipofuscinosis · PLYX

Polaryx Therapeutics

Polaryx Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Paramus, USA HQ
2014 Founded
9 Employees
Public company Type
PLYX · NYSE Ticker
Company details
Status
Public
HQ
Paramus, USA
Founded
2014
Employees
9
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

Polaryx Therapeutics projects

0 ClinicalTrials.gov programs sponsored by Polaryx Therapeutics.

Polaryx Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Polaryx Therapeutics have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.